NEXGEL, Inc. (NXGL)
Largest Insider Buys in Sector
NXGL Stock Price History Chart
NXGL Stock Performance
About NEXGEL, Inc.
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
Insider Activity of NEXGEL, Inc.
Over the last 12 months, insiders at NEXGEL, Inc. have bought $408,120 and sold $13,935 worth of NEXGEL, Inc. stock.
On average, over the past 5 years, insiders at NEXGEL, Inc. have bought $220,884 and sold $13,935 worth of stock each year.
Highest buying activity among insiders over the last 12 months: ZELDIS JEROME B (director) — $174,995. Drapczuk Adam E III (Chief Financial Officer) — $173,126. Henry Scott Robert (director) — $80,000.
The last purchase of 3,636 shares for transaction amount of $9,999 was made by Stein John Nachum (director) on 2024‑11‑20.
List of Insider Buy and Sell Transactions, NEXGEL, Inc.
| 2024-12-20 | Sale | director | 3,000 0.0441% | $4.64 | $13,935 | -1.48% | ||
| 2024-11-20 | director | 3,636 0.0323% | $2.75 | $9,999 | +7.27% | |||
| 2024-11-20 | Chief Executive Officer | 3,636 0.0323% | $2.75 | $9,999 | +7.27% | |||
| 2024-11-20 | director | 9,090 0.0807% | $2.75 | $24,998 | +7.27% | |||
| 2024-11-20 | director | 1,818 0.0161% | $2.75 | $5,000 | +7.27% | |||
| 2024-11-20 | director | 3,636 0.0323% | $2.75 | $9,999 | +7.27% | |||
| 2024-11-20 | Chief Financial Officer | 17,500 0.1553% | $2.75 | $48,125 | +7.27% | |||
| 2024-08-23 | director | 10,000 0.1028% | $2.50 | $25,000 | +11.15% | |||
| 2024-08-23 | director | 10,000 0.1028% | $2.50 | $25,000 | +11.15% | |||
| 2024-08-23 | director | 10,000 0.1028% | $2.50 | $25,000 | +11.15% | |||
| 2024-08-23 | director | 10,000 0.1028% | $2.50 | $25,000 | +11.15% | |||
| 2024-08-23 | Chief Financial Officer | 10,000 0.1028% | $2.50 | $25,000 | +11.15% | |||
| 2024-03-01 | director | 23,697 0.3606% | $2.11 | $50,001 | +6.25% | |||
| 2024-03-01 | director | 11,848 0.1803% | $2.11 | $24,999 | +6.25% | |||
| 2024-03-01 | Chief Financial Officer | 47,394 0.7213% | $2.11 | $100,001 | +6.25% | |||
| 2023-12-22 | director | 3,885 0.0457% | $2.20 | $8,535 | +8.89% | |||
| 2023-09-26 | director | 2,500 0.0453% | $1.96 | $4,900 | +17.37% | |||
| 2023-09-14 | director | 500 0.0086% | $2.27 | $1,135 | -4.16% | |||
| 2023-09-13 | director | 6,000 0.1022% | $2.25 | $13,499 | -1.87% | |||
| 2023-09-12 | director | 4,000 0.069% | $2.28 | $9,115 | -4.41% |
Insider Historical Profitability
| Stein John Nachum | director | 471456 6.9426% | $4.74 | 10 | 0 | +18.2% |
| Levy Adam R. | Chief Executive Officer | 333196 4.9066% | $4.74 | 1 | 0 | |
| glassman steven mark | director | 154155 2.2701% | $4.74 | 6 | 0 | <0.0001% |
| Henry Scott Robert | director | 144553 2.1287% | $4.74 | 14 | 1 | +2.21% |
| ZELDIS JEROME B | director | 106664 1.5707% | $4.74 | 4 | 0 | <0.0001% |